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Introduction
Placental mesenchymal stem cell (PMSC) derived extracellular vesicles (PMSC-EVs)
are lipid-bound vesicles secreted from the cell through different biogenic
pathways including membrane blebbing, budding, and endocytosis and exocytosis
pathways. PMSC-EVs function through intercellular communication by distribution
of their biologically functional cargo including DNA, RNA and proteins. This
biologically functional material can trigger a multitude of physiological responses
such as cellular regeneration and tissue damage response. They have also been
shown to have less toxicity and immunogenicity, ability to encapsulate biologically
active molecules, and ability to cross the blood brain barrier when compared to
cell-based therapies. However, the current applications of PMSC-EVs is limited by
their low yield when produced in conventional monolayer cell culture. The
CELLine bioreactor, which can allow for a high-density three-dimensional (3D) cell
culture within a semipermeable membrane, has been utilized as a large-scale
tissue culture method for producing antibodies as well as for use in cancer EV
related research. In this study, we propose to explore the application of the
CELLine bioreactor as a novel approach to improve the production and yield of
PMSC-EVs for regenerative medicine applications.

Results
Conclusion

Figure 2. NTA results showing total particle count and size distribution of PMSC-EVs

Materials/Methods

The CELLine bioreactor represents a promising new
approach to generate large scale PMSC-EVs. EVS
concentrations and size distribution from the harvest of only
15 mL concentrated conditioned media shows the
improvement and convenience EV isolation from
concentrated 3D culture conditioned medium. When
cultured over an extended time the presence of EV protein
markers and morphologies of EVs remains consistent with
EVs found in conventional culture methods. Although the
CELLine bioreactor shows promise as an alternative method
for the production of PMSC-EVs there are limitations in that
we cannot readily view the cells with a conventional
microscope making it difficult to evaluate the general health
and status of the cells seeded on the polystyrene scaffold.
Because the scaffold is encased in a compartment it is also
difficult to get a total cell count.

Next Steps

Figure 3. CryoEM images of PMSC-EVs from weeks 1 to 8
Figure 1. Components of the 3D culture
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PMSCs were cultured in the CELLine bioreactors, which is comprised of a
polystyrene porous scaffold encased in a 10 kDa semipermeable
membrane creating a cellular compartment with 15 mL Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine
serum that was pre-treated to deplete bovine serum EVs, epidermal
growth factor (EGF), and fibroblast growth factor (FGF) One liter of
DMEM supplemented with EGF and FGF sit above the cellular
compartment in a medium compartment.
PMCS-EVs were isolated from the 15 mL EV rich medium in the cellular
compartment using ultracentrifugation isolation method weekly
Nanoparticle tracking analysis (NTA) was used to quantify concentration.
NTA was used to characterize PMCS-EVs size distribution and relative
charge
Cryogenic electron microscopy (cryoEM) was used to confirm morphology
Western-blot was used to confirm exosome surface proteins CD9 and
CD63 in addition to cytosolic proteins TSG101 and Alix.

• CryoEM showed EVs present with morphologies mirroring
those found in 2D cell culture
• NTA results showed total particle number ranging from
1.03E9-1.31E11 with an initial increase in concentration from
week 1 to week 3 and a decrease there after.
• The size of EVs ranged from 102.2-184 nm all presenting a
negative charged phenotype.
• Western-blot revealed protein expression of EV biomarkers
CD9, CD63, Alix, and TSG101.

Figure 4. Western-Blot: 1-CD-63, 2-CD9, 3Alix, 4-TSG101, 5-Calnexin (-)

Real time cell behavior and status on the 3D matrix can be
monitored by measuring the cell metabolomic activities of
non-invasively sampled culture medium. Proteomics and
RNA seq analyses of PMSC-EVs will also be conducted to
further characterize of PMSC-EVs protein profile and
molecular cargo. PMSC-EV’s neuroprotective function will
also be characterized using established protocols to validate
its therapeutic potency in vitro. To further increase the yield
of EV isolation, we also plan to use new isolation methods,
such as tangential flow filtration and size exclusion
chromatography as alternative isolation methods than
ultracentrifugation
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